青年早新闻｜事关药品医保支付标准 国家医保局公开征求意见

Group 1: Market Competition in Food Delivery Platforms - The State Council's Anti-Monopoly and Anti-Unfair Competition Committee has initiated an investigation into the market competition status of the food delivery platform service industry, based on the Anti-Monopoly Law of the People's Republic of China [2][3] - The investigation aims to address issues such as excessive subsidies, price wars, and traffic control that have been reported in the food delivery sector, which are seen as squeezing the real economy and intensifying "involution" competition [2][3] - The committee will employ methods such as on-site verification, face-to-face interviews, and surveys to gather comprehensive insights into competitive behaviors within the food delivery platforms and will solicit opinions from various stakeholders including operators, new employment groups, and consumers [3] Group 2: Healthcare and Pharmaceutical Regulations - The National Healthcare Security Administration has drafted a consultation document regarding the adjustment of the medical insurance drug catalog, which includes a new communication process for reference drugs [4] - This new process aims to enhance the scientific, fair, and standardized selection of reference drugs, starting with Class 1 new drugs as classified by the National Medical Products Administration [4] - Pharmaceutical companies can voluntarily apply for pre-communication regarding reference drugs, which will be verified for authenticity and completeness before feedback is provided [4][5]